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Abstract Sepsis is associated with depressed T-cell functions 
and increased circulating levels of immunosuppressive agents. 
TGF-ß is a potential anti-inflammatory cytokine that can modify 
T-cell growth and differentiation. The up-regulation of TGF-ß 
and the mechanism of its action on the I -cells during septic 
injury have not been resolved. We hypothesized that in sepsis 
TGF-ß produced by macrophages acts on T-cells in a paracrine 
manner to suppress interleukin (I L)-2 production and prolifera-
tion. In this study, we examined the circulating TGF-ß levels in a 
rat model of Gram-negative bacterial sepsis, and compared the 
abilities of adherent and non-adherent splenocytes to produce 
TGF-ß. Additionally, we investigated the causal relationships of 
hrTGF-ß to concanavalin A (ConA)-induced T-cell responses and 
the intracellular mechanism of the generation of these responses 
in normal splenic rat T-cells. Sepsis was induced in rats by intra-
abdominally implanting fecal pellets containing Escherichia coli 
(150 CFU) and Bacteroides fragilis (10000 CFU). Adherent and 
non-adherent splenocytes were isolated by differential adherence 
using Ficoll gradient centrifugation. T-cells were purified by use 
of Nylon wool columns. We observed a 3-6-fold increase in the 
circulating levels of TGF-ß in sepsis. Western blots and ELISA 
determinations revealed a 2.5-3-fold increase in cell-associated 
TGF-ß protein levels in adherent splenic cells. Northern analyses 
also showed a marked increase in TGF-ß mRNA expression in 
adherent cells during sepsis. On the other hand, a significant 
change was not observed in the TGF-ß protein and mRNA 
expression in non-adherent splenocytes. Pretreatment of control 
rat T-cells with hrTGF-ß decreased both ConA-induced pro-
liferation (by 35^40%) and IL-2 mRNA expression (by > 50%). 
Further, whereas incubation of control rat T-cells with either 
ConA or TGF-ß for 24 h resulted in a 10-15-fold increase in 
cAMP generation, the addition of hrTGF-ß along with ConA 
resulted in a 50-60-fold increase in cAMP. These results suggest 
that in sepsis, TGF-ß produced by splenic macrophages can act 
in a paracrine manner on T-cells to depress their IL-2 mRNA 
expression, IL-2 production and proliferation after up-regulation 
of cAMP which can interfere with T-cell signaling for 
proliferation. 
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1. Introduction 
Severe t rauma and sepsis are associated with depressed T-
cell functions and increased levels of putative immunosuppres-
sive agents such as PGE 2 , IL-4 and IL-10 [1-4]. The immu-
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nosuppressive agents are released by macrophages/monocytes 
[5] and certain T-cells [6], and could adversely affect cell-medi-
ated immunity via interference with the T-cell receptor-medi-
ated early signal transduction steps [7,8]. Previous studies 
from our laboratory indicated that the sepsis-related decrease 
in the T-cell proliferative response could result from an alter-
ation in Ca 2 + ; mobilization in these cells [9]. Furthermore, our 
recent studies have ascertained a potential role of decreased 
Ca 2 + influx in the PGE 2- induced T-cell proliferative suppres-
sion in sepsis [10]. 
Like PGE 2 , T G F - ß might also effect a decrease in cell-medi-
ated immunity during sepsis [7]. An elevation in circulating 
T G F - ß has been correlated with a depression in splenocyte 
IL-2 release in t rauma patients [11,12] and in a murine cecal 
ligation and puncture model of sepsis [13,14]. Fur ther evi-
dence of a role of T G F - ß in sepsis-related suppression in 
immune function comes from experiments which show that 
addition of human T G F - ß to human t rauma patients ' mono-
cytes results in a significant elevation of P G E 2 levels [11]. The 
factors contributing to elevated levels of T G F - ß in sepsis and 
the mechanism of TGF-ß-related T-cell suppression are not 
clearly understood. We hypothesized that in sepsis T G F - ß 
produced by activated macrophages contributes to its elevated 
circulating levels and that in the spleen it may act in a para-
crine manner on T-cells to negatively modulate both their 
IL-2 production and proliferation. Therefore, along with as-
certaining the circulating T G F - ß levels in sepsis, in this study, 
we compared the ability of adherent splenocytes isolated from 
septic and non-septic rats to produce TGF-ß . Additionally, we 
tested the ability of r T G F - ß to modulate T-cell signaling 
events via cyclic A M P (cAMP) generation after their stimula-
tion with concanavalin A (ConA). The generation of c A M P 
was correlated with changes in T-cell IL-2 m R N A expression 
and proliferative responses. 
2. Experimental procedures 
2.1. Rat model of sepsis 
Male Sprague-Dawley rats (250-275 g) obtained from Harlan 
Sprague-Dawley, Inc. (Indianapolis, IN) were used. Sepsis was pro-
duced in rats by implanting into their abdominal cavities fecal pellets 
(1 ml) impregnated with Gram-negative bacteria, Escherichia coli (150 
colony-forming unit (CFU)) and Bacteroides fragilis (104 CFU). The 
rats implanted with pellets without the bacteria are referred to as 
'sterile-implanted'. Details of this rat model of Gram-negative bacte-
rial sepsis have been described previously [15-17]. 
2.2. Preparation of rat splenic cells 
Rats were killed and their spleens were aseptically removed and 
processed to obtain T-cells as described previously [9]. Briefly, spleens 
were gently ground to prepare single-cell suspensions, which were then 
subjected to density gradient centrifugation with Ficoll-Paque (Phar-
macia, Sweden) to remove red blood cells and dead cells. Splenocytes 
appearing at the interphase of Ficoll and HBSS medium (Hank's 
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balanced salt solution) were collected. Splenocytes were then cultured 
for 2-3 h in RPMI-1640 medium (complete with L-glutamine (2 mM), 
2-mercaptoethanol (50 uM), HEPES (10 mM), gentamicin (50 ug/ml) 
and fetal calf serum (10%) in plastic Petrie dishes to separate adherent 
(macrophage-rich) cells from non-adherent cells. For the isolation of 
T-cells, splenocytes were passed through a Nylon wool column pre-
equilibrated with HBSS supplemented with 10 mM HEPES (iV-hy-
droxyethylpiperazine-./V'-2-ethane sulfonic acid), 5% fetal calf serum, 
and 50 ug gentamicin/ml. After 1 h incubation of the columns con-
taining cells at 37°C, T-cells were obtained by eluting the columns 
with 30-35 ml of warm HBSS at a flow rate 1 drop/s. T-cells were 
washed and resuspended in RPMI-1640 (with complete medium) for 
further use. 
2.3. TGF-ß determinations in rat plasma and spleen cells 
Blood was drawn into EDTA-coated tubes via cardiac puncture 
from the non-operated control, sterile- and septic-implanted rats at 
24 and 48 h, and platelet-free plasma separated and stored at —70°C 
until use. Acid-activated plasma TGF-ß levels were measured by ELI-
SA (R&D Systems, Minneapolis, MN) which is specific for the deter-
mination of the TGF-ßi isoform. The assay was sensitive enough to 
detect a minimum of 5 pg/ml of TGF-ß standard in the ELISA pro-
tocol. 
Approximately 10 X 106 adherent or non-adherent cells were lysed 
with lysis buffer followed by cell lysate acid activation for the quanti-
fication of TGF-ß with ELISA. 
2.4. Determination of T-cell proliferation 
The method used for the determination of T-cell proliferation was 
the same as described recently [9]. Briefly, T-cells suspended in com-
plete RPMI-1640 medium and were cultured at a density of 5X105 
cells per well in a 96-well plate at 37°C under 5% C0 2 in air in the 
presence or absence of ConA (5 ug/ml; Sigma Chem. Co., St. Louis, 
MO). After 66 h culture, a trace quantity of [3H]thymidine was added 
to each well, and cultures were maintained for an additional 6 h. Cells 
were harvested on glass fiber filter strips using a 24-well PHD Cell 
Harvester (Cambridge Technology, Cambridge, MA), and thymidine 
radioactivity was determined in a liquid scintillation counter. The 
proliferative response was expressed as radioactivity (disintegrations 
per minute, DPM) incorporated in the cells. 
2.5. Cyclic AMP assay 
cAMP levels of rat splenic T-cells incubated in the absence or pres-
ence of TGF-ß (hrTGF-ßi, Collaborative Biomedical Products, Bed-
ford, MA) and/or ConA were measured using the cAMP[125I] radio-
immunoassay (RIA) kit (Advanced Magnetics, Inc., Cambridge, MA). 
To extract cAMP, T-cells (10xl06/ml, pre-washed in ice-cold PBS) 
were treated with 1 ml of 95% ethanol/5% 0.1 N HC1 (pH 3.0) for 2 h 
at 4°C. The resulting cAMP-containing supernatant was lypophilized 
to powder by speed-vac and re-dissolved in a cAMP assay buffer (100 
mM Tris-HCl, containing 2.6 mM EDTA and 10 mM theophylline). 
A cAMP standard curve was constructed using cAMP in a concen-
tration range of 0.25-50.0 pmol/ml. 
transfer), and UV-cross linked. To detect the IL-2 and TGF-ß mRNA 
expressions, the membranes were prehybridized overnight in an ap-
propriate pre-hybridization solution and then hybridized with 32P-la-
beled cDNA probes of rat IL-2 (400 bp fragment in PCR TMII 
vector; kindly supplied by Dr. Jersey Kupiec-Wiglinski, Harvard 
Medical School, Boston, MA) and TGF-ß (985 bp fragment in pBlue-
script 2KS+ vector; obtained from Dr. G.L. Engelmann of our in-
stitution) at 42°C, overnight. The hybridized filter-membranes were 
washed, and then autoradiographed by exposing the X-ray films at 
—70°C, overnight or as appropriate. 
Uniform RNA loadings were ascertained by stripping and re-prob-
ing the same membrane blots with 32P-labeled ß-actin cDNA probe in 
the same manner. The relative intensity of each band of the mRNA 
expression was quantitated by means of densitometry. Data were 
statistically analyzed using ANOVA. 
3. Results 
Fig. 1 shows plasma TGF-ß levels in septic and non-septic 
rats. The circulating TGF-ß levels in septic-implanted rats 
were significantly higher on days 1 and 2 compared to the 
controls (day 0) and corresponding sterile groups on days 1 
and 2. Compared to controls, the septic animals' TGF-ß levels 
were 3-fold higher on day 1 and more than 6-fold on day 2. 
Although, compared to controls, there was no significant 
change in the sterile rat group on day 1, there was a 3-fold 
increase in the TGF-ß level in sterile rats on day 2. 
The TGF-ß protein contents determined by Western anal-
yses of the adherent splenocytes from control, sterile and sep-
tic rats are shown in Fig. 2. A representative immunoblot is 
shown in Fig. 2A, and the average values obtained after den-
sitometry of the immunoblots are shown in Fig. 2B. During 
sepsis on day 2, there was an approximately 2.7-fold increase 
in cell-associated TGF-ß protein level compared to the con-
trols. No significant changes were observed between the septic 
and sterile groups on day 1, or between the controls (day 0) 
and the two experimental groups on day 1. Also, no signifi-
cant change was observed in TGF-ß protein levels in the day 2 
sterile groups compared to the control or the day 1 experi-
mental groups. TGF-ß protein levels in the non-adherent sple-
2.6. Determination of TGF-$ protein levels by Western analyses 
Adherent and non-adherent splenocytes (10X106 cells) from the 
control, sterile and septic rats on days 1 and 2, post-implantation, 
were lysed with the lysis buffer, and the total protein content of the 
lysates were determined by the dye-binding method [18]. Aliquots of 
equal amount of lysate proteins (usually 10 ug) from the various 
experimental groups were electrophoresed and transferred to nitro-
cellulose membranes and blocked. Using Western blot analysis (Bio-
Rad, Richmond, CA), the membranes were probed with anti-TGF-ßi 
polyclonal antibody (Promega, Madison, WI) to determine the cell-
associated TGF-ß protein levels. 
2.7. RNA preparation and Northern blot analyses 
Total RNA from 100-150X 106 adherent and non-adherent spleno-
cytes as well as from the Nylon wool-purified T-cells of various group 
of animals (treated with ConA for 6 h, and/or TGF-ß for 2 h) was 
isolated using isopycnic centrifugation over a cesium chloride gradient 
[19]. All the RNA sample preparations had A26o and A2so ratio great-
er than 2.0. Aliquots containing equal amounts of RNA (usually 
20 ug) were electrophoretically separated on a formaldehyde-agarose 
gel (1%). RNAs were blot transferred to Nytran membrane (Northern 
Fig. 1. Plasma levels of TGF-ß in control, sterile and septic rats on 
days 1 and 2 after implantations. Values are means (± SE) for at 
least seven animals in each group. *P<0.01 sterile versus septic 
groups on each day. 
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Fig. 3. Western blot detection of TGF-ß from non-adherent splenic 
cells of control, sterile and septic rats on days 1 and 2, post-implan-
tation. The blot is a representative of four similar experiments. No 
significant differences were noted among the experimental groups on 
either time points. 
Fig. 2. A: Western blot detection of TGF-ß from adherent splenic 
cells of control, sterile and septic rats on days 1 and 2, post-implan-
tation. The blot is representative of experimental observations in 
four different animals. B: Densitometric quantitation of Western 
blot analyses of adherent cells from the experimental group of rats 
on days 1 and 2. The values obtained in the control rats were taken 
as 100%. Values are mean (±SE) for four animals in each group. 
*P<0.01 control or sterile versus sepsis on day 2, post-implanta-
tion. 
nocytes were not significantly different in either the septic or 
sterile groups on days 1 and 2 from those in controls (Fig. 3). 
Cell-associated TGF-ß determinations using ELISA (Table 
1) showed quantitative changes in the adherent and non-ad-
herent splenocytes from sterile and septic rats compared to 
controls. On day 1 after the implantations, there was no sig-
nificant change in TGF-ß in the sterile group non-adherent or 
adherent cells compared to controls. However, on day 2, 
TGF-ß levels in both the adherent and non-adherent cells 
from sterile-implanted rats were 35^-0% higher compared to 
the respective controls. A comparable increase in TGF-ß was 
found in both the non-adherent and adherent cells of the 
septic rats on day 1 compared to the controls. In contrast, 
whereas the septic rat non-adherent cells showed only a 60% 
increase on day 2, the septic rat adherent cells of the septic 
rat, the septic rat adherent cell TGF-ß contents were about 
3-fold higher compared to controls. The TGF-ß ELISA evi-
dently provided for a more sensitive and quantitative deter-
mination than that using Western analyses. Whereas Western 
analyses failed to show effects of sterile implantation on days 
1 and 2, or of the septic implantation on day 1 on the TGF-ß 
contents of non-adherent or adherent splenocytes compared 
to controls, ELISA determinations showed 35-60% elevations 
in cell-associated TGF-ß levels in these groups. However, it 
should be noted that the substantially greater effect of sepsis 
on day 2 in the adherent cell TGF-ß levels than in the non-
adherent cells was clearly demonstrateable with both Western 
analysis and ELISA. These results support that a distinct day 
2-sepsis-related increase in TGF-ß protein expression occurs 
in the macrophage-rich adherent splenocyte population and 
that a relatively modest increase occurs in the sterile and the 
day 1-sepsis group adherent as well as non-adherent cells. The 
modest increases in TGF-ß levels may represent effect of non-
septic inflammatory responses on the macrophages and a con-
tamination of non-adherent cells with macrophage products. 
Because both the circulating as well as the cell-associated 
TGF-ß protein levels were found to be elevated in the septic 
animals on day 2 (post-implantation) relative to on day 1, the 
assessments of TGF-ß mRNA expressions in adherent and 
non-adherent splenic cells from sterile and septic animals 
were carried out on day 2 only. Fig. 4A is a representative 
32P-labeled Northern blot showing a marked increase in TGF-
ß mRNA expression in adherent splenocytes from septic rats 
compared to the control and sterile rat groups. The densito-
metric analyses of these blots showed an approximately 1.8-
fold increase in the sterile group, and a 3.5-fold increase in 
mRNA abundance in the septic group of animals (Fig. 4B). 
Unlike the changes in TGF-ß mRNA expressions in the ad-
herent splenic cells, no significant differences were noted in the 
mRNA abundance in the non-adherent splenic cells from the 
septic and non-septic animals (Fig. 5A,B). 
To investigate causal relationships between TGF-ß and 
Table 1 
Effect of sepsis on non-adherent and adherent splenocyte TGF-ß contents (pg/106 cells) as determined by ELISA 
Cell types/days-post-implant Animal groups 
Control Sterile Septic 
Non-adherent cells 
Day 0 
Day 1 
Day 2 
Adherent cells 
Day 0 
Day 1 
Day 2 
161.617.1 
164.5 ±7.3 
177.1 ±16.4 
223.1 ±11.3 
190.8 ±14.9 
232.2± 11.1 
236.3 ±12.1 
259.6 ±6.6 
229.3 ±16.7 
474.8 ± 19.6 
Values are means (± SE) of 3-4 unoperated control (Control), sterile-implanted (Sterile), or septic implanted (Septic) rats. 
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Fig. 4. A: 32P-labeled Northern blot detection of TGF-ß mRNA ex-
pression in adherent cells obtained from control, sterile and septic 
rats on day 2, post-implantation. The blot is representative of four 
experimental observations. B: Densitometric analyses of the four 
such Northern blots of TGF-ß mRNA expressions in adherent cells. 
The values of the mRNA abundance computed in the controls were 
taken as 100%. Values are mean (±SE) for four experiments in 
each group. *P<0.05, control versus sterile or sterile versus sepsis; 
"P<0.01, control versus sepsis. 
pared to the control) for 24 h, but not in the cells exposed for 
only 2 or 8 h. The addition of hrTGF-ß along with ConA 
resulted in a much greater increase in cAMP generation (50-
60-fold, P< 0.0001) after 24 h incubation of T-cells (Fig. 7). 
Because of the marked increases in ConA-induced cAMP 
generation by TGF-ß after the incubation of T-cells for 24 h, 
the effect of TGF-ß on the lymphokine (IL-2) production was 
also examined at this time point. Fig. 8A showing a Northern 
blot of the 32P-labeled IL-2 mRNA expression level in normal 
rat splenic T-cells. The relative percentage of the IL-2 mRNA 
expression as quantitated by densitometry is shown in Fig. 
8B. Data suggest that pre-treatment of control rat T-cells 
with rTGF-ß (2.5 ng/ml) leads to a decrease in ConA-induced 
IL-2 mRNA expression by more than 50% (P< 0.001). 
4. Discussion 
The present study demonstrated significantly elevated levels 
of circulating TGF-ß in septic rats, and correlatable changes 
T-cell proliferation, lymphokine production and signaling, we 
studied the effect of exogenously added hrTGF-ß on control 
rat T-cell proliferative response to ConA, and ConA-mediated 
IL-2 mRNA expression, in vitro. The proliferative responses 
of T-cells to ConA were assessed in the presence of different 
doses of rTGF-ß and its absence as shown in Fig. 6. At 72 h 
of incubation, the ConA-mediated T-cell proliferative re-
sponses were significantly depressed (35^10% decrease, 
P<0.05) in the presence of TGF-ß at concentrations of 2.5 
and 25.0 ng/ml. Since 2.5 ng/ml TGF-ß concentration was 
sufficient to inhibit the T-cell proliferative response, we chose 
to use this concentration for the experiments on the effect of 
TGF-ß on T-cell IL-2 mRNA expression and the generation 
of cyclic AMP. 
The effect of hrTGF-ß (2.5 ng/ml) on T-cell cAMP gener-
ation is shown in Fig. 7. It is clear from the figure that a 
significant increase (10-15-fold, P< 0.001) in cAMP levels 
was observed in T-cells exposed to ConA or rTGF-ß (corn-
Fig. 5. A: Northern blot of TGF-ß mRNA expression in non-ad-
herent splenic cells from the control, sterile and septic rats on day 
2, post-implantation. The blot is representative of observations in 
four different animals. B: Densitometric quantitation of four such 
blots of TGF-ß mRNA expressions in non-adherent cells. The val-
ues taken as 100% were from the mRNA expression detected in the 
control animals. Values are mean (± SE) for four animals in each 
group. No significant differences (P>0.05) were observed among 
the experimental groups. 
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Fig. 6. Effect of varying concentration of hrTGF-ß on ConA-in-
duced T-cell proliferative response in control rats. Values are means 
(±SE) for six animals. *P<0.01, T-cells incubated with rTGF-ß 
versus T-cells without rTGF-ß. 
in the levels of TGF-ß protein and mRNA expressions in 
adherent splenocytes. Some of these observations are in keep-
ing with the previous studies on highly in vivo activated mac-
rophages from trauma patients [11], and in a murine cecal 
ligation and puncture model of polymicrobial sepsis [14]. Mil-
ler-Graziano et al. [11] showed that following the injury, pa-
tients who were immunosuppressed and would typically die 
due to septic complications possessed blood monocytes that 
exhibited an enhanced capacity to produce TGF-ß. Other 
studies [20-23] have indicated that the enhanced TGF-ß pro-
duction under injury conditions is related with the increased 
release of another potent immunosuppressant such as PGE2. 
TGF-ß can act as a stimulus for prostanoid release which in 
turn could contribute to immunosuppression [11,24]. Thus, it 
is clear that the release of TGF-ß in sepsis could play a role in 
the network of events that lead to host immunosuppression. 
Although not of the same magnitude as found in the septic 
rats, the observed increase in circulating TGF-ß levels in the 
sterile-implanted animals on day 2, but not on day 1, could be 
due to the surgical stress to animals because simple laparot-
omy in itself can affect immune functions [25]. While no sub-
stantial alterations could be observed during sepsis in non-
adherent splenic cells in terms of TGF-ß protein contents on 
days 1 or 2, we observed an approximately 2.5-3.0-fold in-
crease in TGF-ß protein levels in adherent cells of septic rats 
compared to the controls or sterile groups on day 2 post-
implantation. Similarly, we observed an overexpression of 
TGF-ß mRNA abundance in adherent splenic cells in sepsis 
on day 2 without any significant changes in non-adherent cells 
of the experimental groups. The observed overexpression of 
TGF-ß mRNA abundance in adherent splenic (macrophage-
enriched) cells in sepsis on day 2, but not in non-adherent 
splenic cells could be due to a transcriptional up-regulation 
of TGF-ß in sepsis. The ability of adherent cells to produce 
greater quantities of TGF-ß protein as well as its mRNA after 
the onset of sepsis implies that TGF-ß released from tissues 
such as spleen could be the source of circulating TGF-ß in 
septic animals. We can not, however, rule out the possibility 
of release of TGF-ß into plasma from other sources such as 
macrophages and monocytes. 
Several studies have suggested the inhibitory effect of TGF-
ß on T-cell proliferation in clinical and experimental injury 
conditions such as trauma, burn and hemorrhagic shock 
[11,14,26,27]. However, to date, there is little information 
available on the potential mechanisms of action of TGF-ß 
on T-cells. In our studies, we investigated through in vitro 
experiments the causal relationships of TGF-ß to T-cell re-
sponses and the intracellular mechanism of the generation 
of these responses. Our hypothesis has been that in sepsis, 
TGF-ß produced by splenic macrophages acts on adjacent 
T-cells to modulate their IL-2 mRNA expression, IL-2 pro-
duction and proliferation after affecting T-cell signaling events 
that are responsible for the elicitation of these responses. Our 
results on the capacity of rTGF-ß to modulate ConA-induced 
T-cell proliferation and IL-2 mRNA expression and to aug-
ment cAMP generation ascertained that this anti-inflamma-
tory cytokine does play a role during the development of 
T-cell suppression in the course of sepsis. Our results support 
such a role of TGF-ß via its paracrine effect on the T-cells 
within the spleen. 
An elevation in cAMP production in T-cells subsequent to 
the action of PGE2 on these cells is known to effect a decrease 
in T-cell activation, IL-2 production and proliferation [28-31]. 
Previous studies from out laboratory have shown an involve-
ment of PGE2 in the alteration of T-cell Ca2+¡ signaling which 
leads to suppressed T-cell response in sepsis [10]. The present 
study showing the direct effect of rTGF-ß in enhancing T-cell 
cAMP levels suggests that like PGE2, TGF-ß also effects T-
cell cAMP accumulation to cause the suppression of the pro-
liferative response in these cells. PGE2 has been shown to 
down-regulate the IL-2 gene transcription by interfering 
with Ca2+i-mediated activation of calcineurin [32]. We spec-
Fig. 7. Effect of hrTGF-ß (2.5 ng/ml) and/or ConA (5 ug/ml) on 
control rat T-cell cAMP generation at various time points. Values 
are means (±SE) for six animals. *P<0.05, control versus T-cells 
incubated with rTGF-ß; +P<0.01, control versus T-cells with 
ConA; ++P< 0.001, control versus T-cells treated with both rTGF-
ß and ConA. 
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